Developments in the treatment of HIV and chronic hepatitis C Virus Infections - A report from CROI 2015

Research output: Contribution to journalArticle


The Conference on Retroviruses and Opportunistic Infections (CROI) 2015 took place February 23-26, 2015, in Seattle, Washington, and brought together researchers from around the world to share important developments and findings in the field of HIV Medicine and related infectious diseases. This report focuses on studies of new antiretroviral drugs and anti-hepatitis C virus therapies that were presented at CROI 2015.

Original languageEnglish (US)
Pages (from-to)323-328
Number of pages6
JournalDrugs of the Future
Issue number5
StatePublished - May 1 2015



  • Asunaprevir
  • Beclabuvir
  • Cabotegravir
  • Daclatasvir
  • Dasabuvir
  • Ledipasvir
  • Ombitasvir
  • Paritaprevir
  • Sofosbuvir
  • Tenofovir alafenamide fumarate

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this